These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 31115188)
1. Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy. Moreau J; Ordan MA; Barbe C; Mazza C; Perrier M; Botsen D; Brasseur M; Portefaix C; Renard Y; Tallière B; Bertin E; Hoeffel C; Bouché O Cancer Med; 2019 Jul; 8(8):3677-3684. PubMed ID: 31115188 [TBL] [Abstract][Full Text] [Related]
2. Dynapenia in digestive cancer outpatients: association with markers of functional and nutritional status (the FIGHTDIGO study). Perrier M; Ordan MA; Barbe C; Mazza C; Botsen D; Moreau J; Renard Y; Brasseur M; Tailliere B; Regnault P; Bertin E; Bouche O Support Care Cancer; 2022 Jan; 30(1):207-215. PubMed ID: 34251540 [TBL] [Abstract][Full Text] [Related]
3. Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients. Botsen D; Ordan MA; Barbe C; Mazza C; Perrier M; Moreau J; Brasseur M; Renard Y; Taillière B; Slimano F; Bertin E; Bouché O BMC Cancer; 2018 Oct; 18(1):955. PubMed ID: 30286724 [TBL] [Abstract][Full Text] [Related]
4. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer. Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241 [TBL] [Abstract][Full Text] [Related]
5. Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Martin P; Botsen D; Brugel M; Bertin E; Carlier C; Mahmoudi R; Slimano F; Perrier M; Bouché O Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364711 [TBL] [Abstract][Full Text] [Related]
6. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study. Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus. Andreo-López MC; Zarco-Martín MT; Contreras-Bolívar V; Fernández-Soto ML Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068772 [TBL] [Abstract][Full Text] [Related]
8. Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancers. Nasu N; Yasui-Yamada S; Kagiya N; Takimoto M; Kurokawa Y; Tani-Suzuki Y; Kashihara H; Saito Y; Nishi M; Shimada M; Hamada Y Nutrition; 2022; 103-104():111826. PubMed ID: 36122543 [TBL] [Abstract][Full Text] [Related]
9. Normative cutoffs of muscle mass, muscle strength, and frailty for healthy Indian population. Singh SA; Madan K; Prabhudesai AA; Agarwal AR; Rastogi R; Bhargava R; Kriplani P; Pampaniya H; Gupta S; Indrayan A Indian J Gastroenterol; 2022 Dec; 41(6):591-598. PubMed ID: 36602720 [TBL] [Abstract][Full Text] [Related]
10. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. Anand A; Mohta S; Agarwal S; Sharma S; Gopi S; Gunjan D; Madhusudhan KS; Singh N; Saraya A J Clin Exp Hepatol; 2022; 12(1):52-60. PubMed ID: 35068785 [TBL] [Abstract][Full Text] [Related]
11. Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis. De A; Kumari S; Kaur A; Singh A; Kalra N; Singh V Indian J Gastroenterol; 2022 Jun; 41(3):284-291. PubMed ID: 35852763 [TBL] [Abstract][Full Text] [Related]
12. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Muscle Mass and Malnutrition in Patients with Colorectal Cancer Using the Global Leadership Initiative on Malnutrition Criteria and Comparing Bioelectrical Impedance Analysis and Computed Tomography Measurements. de Luis Roman D; López Gómez JJ; Muñoz M; Primo D; Izaola O; Sánchez I Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275350 [TBL] [Abstract][Full Text] [Related]
14. Effect of low skeletal muscle mass combined with low muscle strength to predict survival in patients with incurable cancer. Calixto-Lima L; de Oliveira LC; Pimenta NG; de Albuquerque NMC; Chaves GV; Wiegert EVM Clin Nutr ESPEN; 2022 Oct; 51():445-451. PubMed ID: 36184241 [TBL] [Abstract][Full Text] [Related]
15. Malnutrition in Relation to Muscle Mass, Muscle Quality, and Muscle Strength in Hospitalized Older Adults. Xie L; Jiang J; Fu H; Zhang W; Yang L; Yang M J Am Med Dir Assoc; 2022 May; 23(5):722-728. PubMed ID: 34953766 [TBL] [Abstract][Full Text] [Related]
16. Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis. Singh S; Taneja S; Roy A; Rathi S; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V Indian J Gastroenterol; 2023 Jun; 42(3):379-387. PubMed ID: 37222972 [TBL] [Abstract][Full Text] [Related]
17. Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis. Bocchino M; Alicante P; Capitelli L; Stanziola AA; Gallotti L; Di Gregorio A; Rea G; Sanduzzi Zamparelli A; Scalfi L Sci Rep; 2021 Sep; 11(1):17884. PubMed ID: 34504219 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of low computed tomography-measured skeletal muscle index and handgrip strength in a general medical population. Van Jacobs A; Coltman A; Gomez-Perez SL; Bienia B; Sclamberg JS; Peterson SJ Nutr Clin Pract; 2022 Feb; 37(1):102-109. PubMed ID: 33930219 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study. Ordan MA; Mazza C; Barbe C; Perrier M; Botsen D; Renard Y; Moreau J; Brasseur M; Taillière B; Bertin É; Bouché O Cancer; 2018 Apr; 124(7):1501-1506. PubMed ID: 29278424 [TBL] [Abstract][Full Text] [Related]
20. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients. Luengpradidgun L; Chamroonkul N; Sripongpun P; Kaewdech A; Tanutit P; Ina N; Piratvisuth T BMC Gastroenterol; 2022 Mar; 22(1):159. PubMed ID: 35354434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]